0001367644-20-000013.txt : 20200225
0001367644-20-000013.hdr.sgml : 20200225
20200225163042
ACCESSION NUMBER: 0001367644-20-000013
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200221
FILED AS OF DATE: 20200225
DATE AS OF CHANGE: 20200225
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Richard Ronald
CENTRAL INDEX KEY: 0001380177
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33137
FILM NUMBER: 20651120
MAIL ADDRESS:
STREET 1: 2273 RESEARCH BLVD, SUITE 400
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Emergent BioSolutions Inc.
CENTRAL INDEX KEY: 0001367644
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 141902018
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 400 PROFESSIONAL DR, SUITE 400
CITY: GAITHERSBURG
STATE: MD
ZIP: 20879
BUSINESS PHONE: 240-631-3200
MAIL ADDRESS:
STREET 1: 400 PROFESSIONAL DR, SUITE 400
CITY: GAITHERSBURG
STATE: MD
ZIP: 20879
4
1
wf-form4_158266622472686.xml
FORM 4
X0306
4
2020-02-21
0
0001367644
Emergent BioSolutions Inc.
EBS
0001380177
Richard Ronald
400 PROFESSIONAL DR, SUITE 400
GAITHERSBURG
MD
20879
1
0
0
0
Common Stock
2020-02-21
4
M
0
5152
18.64
A
31851
D
Common Stock
2020-02-21
4
S
0
5152
65
D
16395
D
Employee Stock Options (Right to Buy)
18.64
2020-02-21
4
M
0
5152
18.64
D
2017-05-21
2021-05-21
Common Stock
5152.0
7893
D
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Richard.
Consists of an option granted under the company's stock incentive plan as amended and restated.
The option grant vests in three equal installments on the day prior to the first, second and third anniversary dates of the grant. The date herein represents the third anniversary date of the grant and the final vesting date.
/s/ S. Scott Lieberman, Attorney-in-fact
2020-02-25